-
The Growing Role of Real-World Evidence (RWE) to Support Efficacy in EMA Oncology Approvals: Light at the End of the Tunnel
Sep 9, 2025, 16:22 PM -
Assessing the Psychometric Performance of the Experimental EQ-TIPS V20 in Assessing the Health-Related Quality of Life of Stunted Children in Laos
Sep 9, 2025, 16:22 PM -
Patient-Centered PICO Scoping in EU HTA: A Pilot Study for Structured Consensus Building Using a Delphi Panel
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial
Sep 9, 2025, 16:22 PM -
Increased Functional Impairment Associated With Generalized Anxiety Disorder (GAD): Findings From a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Shortage of Antineoplastics and Supportive Medicines in Armenia
Sep 9, 2025, 16:22 PM -
Individual Therapy or No Therapy at All: Impact of Patient Individual Therapies As ACT in the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements
Sep 9, 2025, 16:22 PM -
Strengthening Routine Childhood Immunization Post-COVID: Global Strategies to Improve Coverage and Equity
Sep 9, 2025, 16:22 PM -
The Impact of Annual Price Revision Based on External Reference Pricing on Medicines Between 2012 and 2023 in Portugal
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Ondansetron Oral Dissolving Film vs. Oral Solution in the Chemotherapy-Induced Nausea and Vomiting for Egyptian Pediatric Patients
Sep 9, 2025, 16:22 PM -
Bigger, Better Studies: Prioritizing Literature Review Using an Approach Based on Large Language Models
Sep 9, 2025, 16:22 PM -
Population Impact of Performing BRCA1/2 Testing to Guide Metastatic Castration-Resistant Prostate Cancer Treatment in Spain
Sep 9, 2025, 16:22 PM -
Comparing Key European HTA Body Methodological Standards for Systematic Reviews of Economic and Utility Evidence
Sep 9, 2025, 16:22 PM -
Danicopan in Addition to the Component 5 Inhibitor C5i Ravulizumab for the Treatment of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Residual Hemolytic Anemia in Greece: A Cost Utility Analysis
Sep 9, 2025, 16:22 PM -
The Key Role of Social Participation in Health Technology Assessment: Experiences From South American Countries
Sep 9, 2025, 16:22 PM -
Humanistic and Financial Burden Experienced by Nonprofessional Care Partners of Patients With Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease: Results From a Real-World Survey in Spain
Sep 9, 2025, 16:22 PM -
Reframing Pharmaceutical Pricing: Implications of the 2025 SVR Report for Germany’s Pricing Logic and International Spillovers
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM
